Cargando…
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
Transplant recipients, who receive therapeutic immunosuppression to prevent graft rejection, are characterized by high coronavirus disease 2019 (COVID-19)-related mortality and defective response to vaccines. We observed that previous infection with severe acute respiratory syndrome coronavirus 2 (S...
Autores principales: | Charmetant, Xavier, Espi, Maxime, Benotmane, Ilies, Barateau, Véronique, Heibel, Francoise, Buron, Fanny, Gautier-Vargas, Gabriela, Delafosse, Marion, Perrin, Peggy, Koenig, Alice, Cognard, Noëlle, Levi, Charlène, Gallais, Floriane, Manière, Louis, Rossolillo, Paola, Soulier, Eric, Pierre, Florian, Ovize, Anne, Morelon, Emmanuel, Defrance, Thierry, Fafi-Kremer, Samira, Caillard, Sophie, Thaunat, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939774/ https://www.ncbi.nlm.nih.gov/pubmed/35103481 http://dx.doi.org/10.1126/scitranslmed.abl6141 |
Ejemplares similares
-
L’immunosuppression et le défaut d’immunogénicité des vaccins à ARNm limitent la protection des patients transplantés vaccinés selon le schéma standard : plaidoyer pour une 3(e) dose
por: Charmetant, X., et al.
Publicado: (2021) -
Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021) -
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021) -
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
por: Benotmane, Ilies, et al.
Publicado: (2022) -
A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)